| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | -0.24 | 0.1 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | 0.079 | 0.1 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.074 | 0.1 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |